Drug effects on platelet adherence to collagen and damaged vessel walls
- PMID: 364949
- DOI: 10.1007/978-1-4684-0967-3_14
Drug effects on platelet adherence to collagen and damaged vessel walls
Abstract
The interaction of platelets with damaged vessel walls leads to the formation of platelet-fibrin thrombi and may also contribute to the development of atherosclerotic lesions because platelets adherent to exposed collagen release a mitogen that stimulates smooth muscle cell proliferation. The first step in thrombus formation, platelet adherence to an injured vessel wall, can be studied quantitatively by the use of platelets labeled with 51chromium. In these investigations, rabbit aortas were damaged by passage of a balloon catheter and segments of the aortas were everted on probes that were rotated in platelet suspensions. Collagen-coated glass cylinders were also used. Adherence was measured in a medium containing approximately physiologic concentrations of calcium, magnesium, protein and red blood cells. Conditions of testing influence the effect of non-steroidal anti-inflammatory drugs, sulfinpyrazone, and dipyridamole on platelet adherence. Aspirin and sulfinpyrazone were not inhibitory when tested in a medium with a 40% hematocrit; this indicates that products formed by platelets from arachidonate probably do not play a major part in the adherence of the first layer of platelets to the surface, although they may be involved in thrombus formation. Indomethacin, dipyridamole, prostaglandin E1, methylprednisolone and penicillin G and related antibiotics did inhibit platelet adherence although the concentrations required were higher than would likely be achieved in vivo upon administration to human patients. None of the non-steroidal anti-inflammatory drugs inhibited the release of granule contents from adherent platelets. Pretreatment of the damaged vessel wall with aspirin increased platelet adherence, presumably because it prevented the formation of PGI2 by the vessel wall. Platelet adherence to undamaged or damaged vessel walls was enhanced by prior exposure of the wall to thrombin. Platelet reactions with aggregating agents and platelet survival can be modified by changes in dietary lipids but there is very little evidence concerning the effects of lipids on platelet adherence. If some forms of dietary fat damage the endothelium, platelet interaction with the damaged area and release of the mitogen for smooth muscle cells would contribute to the development of atherosclerotic lesions.
Similar articles
-
Platelet interactions with the endothelium and the subendothelium: the role of thrombin and prostacyclin.Haemostasis. 1979;8(3-5):183-92. doi: 10.1159/000214310. Haemostasis. 1979. PMID: 389756
-
Platelet adhesion.Prog Hemost Thromb. 1984;7:211-88. Prog Hemost Thromb. 1984. PMID: 6397767 Review.
-
The role of platelets in the development and complications of atherosclerosis.Semin Hematol. 1986 Jan;23(1):8-26. Semin Hematol. 1986. PMID: 3511536 Review.
-
Inhibition of platelet adherence to damaged surface of rabbit aorta.J Lab Clin Med. 1975 Oct;86(4):551-63. J Lab Clin Med. 1975. PMID: 1176809
-
The influence of red blood cells on the effects of aspirin or sulphinpyrazone on platelet adherence to damaged rabbit aorta.Br J Haematol. 1979 Jun;42(2):283-91. doi: 10.1111/j.1365-2141.1979.tb01132.x. Br J Haematol. 1979. PMID: 465372
Cited by
-
Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase.J Clin Invest. 1984 Nov;74(5):1842-9. doi: 10.1172/JCI111603. J Clin Invest. 1984. PMID: 6389600 Free PMC article.
-
Modification of atherosclerosis by agents that do not lower cholesterol.Br Heart J. 1993 Jan;69(1 Suppl):S54-62. doi: 10.1136/hrt.69.1_suppl.s54. Br Heart J. 1993. PMID: 8427766 Free PMC article. Review. No abstract available.
-
Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum. Possible role of calcium in atherogenesis.J Clin Invest. 1980 May;65(5):967-81. doi: 10.1172/JCI109783. J Clin Invest. 1980. PMID: 7364947 Free PMC article.